Introduction：Basic information about PHYTOHEMAGGLUTININ PHA-M CAS 9008-97-3, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
PHYTOHEMAGGLUTININ PHA-M Basic information
| Product Name: | PHYTOHEMAGGLUTININ PHA-M |
| Synonyms: | LEUCOAGGLUTININ (PHA-L);Agglutinin from soybean;PHA-C;PhytohemagglutininPhaseolus vulgaris agglutinin, PHA;pigeonpeaphytohemagglutinin;RED KIDNEY BEAN LECTIN;PHASEOLUS VULGARIS AGGLUTININ;PHASEOLUS VULGARIS AGGLUTININ PHA-L |
| CAS: | 9008-97-3 |
| MF: | |
| MW: | 0 |
| EINECS: | 232-718-7 |
| Product Categories: | Intermediate |
| Mol File: | Mol File |
|
PHYTOHEMAGGLUTININ PHA-M Chemical Properties
| storage temp. | Sealed in dry,2-8°C |
| solubility | PBS: 2 mg/mL |
| form | salt-free, lyophilized powder |
| color | White to light yellow |
| biological source | Phaseolus vulgaris |
| Cosmetics Ingredients Functions | SKIN CONDITIONING - MISCELLANEOUS |
Safety Information
| Safety Statements | 22-24/25 |
| WGK Germany | WGK 3 |
| RTECS | TJ3470000 |
| F | 10-21 |
| Storage Class | 11 - Combustible Solids |
PHYTOHEMAGGLUTININ PHA-M Usage And Synthesis
| Uses | Phytohemagglutinin-M (PHA-M) has been used in the activation of Jurkat and primary cells. It has also been used to treat polymorphonuclear blood cells(PMBCs) |
| General Description | Lectins are distinct proteins or glycoproteins that have at least one non-catalytic domain which fixes reversibly to a definite mono- or oligosaccharide. Some of their potentially utilizable biological assets include: antitumor, immunomodulatory and anti-insect, antifungal, antibacterial, anti-HIV, and mitogenic properties. |
| Biochem/physiol Actions | Phytohemagglutinin (PHA) has mitogenic and potent cell agglutinating activities. It binds to T-cell membranes and stimulates cell division and metabolic activity. PHA has the ability to stimulate close contacts between cell membranes. |
| in vivo | Phytohemagglutinin (100 μg; i.p.; daily for 2 days) inhibits A20 tumor growth[1]. | Animal Model: | CB17-SCID Mice (bearing A20 cells)[1] | | Dosage: | 100 μg | | Administration: | I.p.; daily for 2 days | | Result: | Inhibited A20 tumor growth. |
|
PHYTOHEMAGGLUTININ PHA-M Preparation Products And Raw materials
